$NWG

NatWest (NWG) Q3 2026 Earnings Call Transcript

NatWest (NWG) reported Q3 2026 earnings with income growth of 9.3%, cost growth of 4.8%, and a cost-income ratio of 45.7%. Earnings per share rose 13.2% to 57.4 pence. The bank's capital ratio stands at 13.5%, with a return on tangible equity of 20.2%. Full-year income is expected to reach around GBP 17.9 billion, excluding notable items. The impairment charge was GBP 277 million, and the CET1 ratio is 13.5% after distributions.

Original reporting
Published Oct 30, 2026, 3:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 3:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
NatWest (NWG) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$NWGBullishMed
01

Why it matters

The most tradable elements are unchanged 2026 guidance, the expected BoE base rate path assumption for Q4, the impairment and cost-of-risk framing, and the confirmed Pillar 2A reduction effective Jan 1, 2027, which affects CET1 requirements and capital planning.

02

Market read

Provides concrete Q3 operating metrics and explicit capital/guidance updates that can drive near-term positioning in UK bank stocks.

03

What to watch

The transcript references inclusion of Evelyn Partners and a gain on sale of an SME consultancy business, so traders may discount parts of income/cost performance that are not purely organic.

Relevance 7/10Novelty 6/10Timing: ahead of next quarter positioning, with rate-path assumption for Q4 and Jan 1, 2027 capital changes.

Background

This is a Q3 2026 earnings call transcript for NatWest, comparing Q3 versus Q2 and discussing integration progress, capital, impairments, and guidance.

Company-level read

Ticker impact

$NWGBullishMedium confidence
Context

NatWest’s Q3 call reiterates 2026 guidance and details capital, impairments, and a planned Pillar 2A reduction from Jan 1, 2027.

Expected impact

Likely modest upward bias as traders focus on unchanged 2026 income guidance, improving cost income ratio, and lower Pillar 2A requirements.

Evidence & confidence

The transcript provides specific Q3 performance (income growth, cost growth, impairment charge) plus explicit regulatory capital relief (Pillar 2A reduction) and unchanged 2026 guidance, which are direct inputs to valuation and capital planning.

Market effects

UK bank peers may see read-across on credit resilience, operating leverage, and how Basel 3.1/CRD IV and Pillar 2A changes flow into CET1 headroom.

Could modestly influence UK financials sentiment as traders price UK rate sensitivity and capital relief timing across the sector.

Limited direct global spillover, but reinforces broader bank themes of capital optimization and rate-driven NIM dynamics.

Counterpoint

The call’s positive tone may be offset by the assumption that BoE base rates rise to 4% in Q4, meaning results could disappoint if the rate path shifts lower.

Key entities

  • NatWest

    UK bank reporting Q3 2026 results and guidance, including capital ratios, impairment charges, and Pillar 2A requirement reduction.

  • Evelyn Partners

    Mentioned as included in results via acquisition integration, with cost and capital impacts discussed.

  • Bank of England

    Rate-path assumption discussed, with base rates expected to increase to 4% in Q4.

Related articles

$NWGMed

NatWest cuts 1,400 jobs in £420m cost-saving drive

NatWest reported a 2% increase in operating pre-tax profit to £2.2b for Q3, with net interest income up 9% to £3.6b. The bank cut 1,400 jobs and saved £420m in costs, while investing in AI and tech. CEO Paul Thwaite noted economic resilience but higher fuel spending. Mortgage balances increased due to remortgaging.

$AZNHighAI 8/10

FTSE 100 Poised for Monthly Gains as AstraZeneca Surges on Results

The FTSE 100 was up 0.1% on Friday, heading for a monthly gain, as AstraZeneca rose 3.6% after announcing a restructuring plan to save $1.5 billion. The broader pharma sector gained 3%. Banks weighed on the index, with NatWest down 7.9% after disappointing earnings. Oil prices rose 2%, and energy stocks gained 0.2%. Inflation data earlier in the month suggested a potential rate hike by the Bank of England in November.

$NWGHighAI 8/10

NatWest shares fall after muted quarter as profit growth stalls

NatWest reported a £2.2bn pre-tax profit for Q3, up 1.9% YoY, but missed net interest income forecasts. Shares fell 8% as profit growth stalled. Wealth revenue surged 47% due to the Evelyn Partners acquisition. Non-interest income exceeded expectations, while net interest income fell short. The bank anticipates a BoE rate hike to 4% and faces a tax surcharge increase from January.

$AZNHighAI 8/10

Astrazeneca posts solid Q3 numbers, NatWest Q3 profits slip

AstraZeneca reported Q3 revenue growth of 7% to $16.21bn and core EPS up 17% to $2.79. NatWest's Q3 profits fell to £1.5bn from £1.6bn a year earlier. Binance is investigating a potential $6.3bn security breach. Amazon missed Q3 sales and profit expectations, with revenue up 12% to $201.9bn and net income down 2.4% to $20.7bn.